Together We Succeed

Ophidion CNS Carrier Technology

  • Ophidion’s CNS Carrier Technology (or OCCT) is available for partnering.

 

  • We look forward to enabling third parties to enhance the penetration of their pipeline or marketed products (life cycle management) to the brain.

 

  • OCCT can be coupled with small molecules, including peptides, gene silencing therapeutics ( siRNAs and ASOs), and other macromolecules (e.g. antibodies, oligonucleotides, etc.).

Ophidion’s CNS Pipeline

  • Ophidion is looking to develop other pipeline products to preclinical proof of concept before out-licensing them to third parties.

  • Co-development partners for the Huntington’s (OCCT-HTT siRNA) and cognition (OCCT-lynx1 siRNA) programs in the USA

Partnering Opportunities

Ophidion’s CNS Carrier Technology (OCCT)

  • Available for partnering with third parties’ pipeline or marketed products

Huntington’s Disease
(OCCT-HTT siRNA/HTT ASO)

  • Available for partnering in ex-U.S. regions (Europe, China, and Japan)

  • For the U.S.: looking for co-development partners

Cognition (OCCT-lynx1 siRNA)

  • Available for partnering on a world-wide basis

Other Pipeline Products

  • Parkinson’s Disease

  • Progressive Supranuclear Palsy

  • Alzheimer’s Disease

  • Amyotrophic Lateral Sclerosis (ALS)

  • ALS / Frontotemporal Dementia

  • Glioblastoma multiforme

Available for out-licensing on a worldwide basis

Contact

Interested in partnering, contact Yacoub Habib, CEO.
Tel: (973) 687-2165
Email: [email protected]